Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Weekly News Recap #Phispers
1. 2649467-58-1
2. 2-pyridinecarboxamide, 4-[[[(2r,3s,4s,5r)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-
3. Suzetrigine [inn]
4. Log73m21h5
5. Schembl23462160
6. Gtpl12630
7. Vx548
8. Ex-a7354
9. Vx-548
10. Compound 7 [wo2021113627a1]
11. Hy-148800
12. Cs-0641183
13. 4-[(2r,3s,4s,5r)-3-(3,4-difluoro-2-methoxyphenyl)-4,5- Dimethyl-5-(trifluoromethyl)oxolane-2- Carboxamido]pyridine-2-carboxamide
14. 4-[[(2r, 3s, 4s, 5r)-3-(3, 4-difluoro-2-methoxyphenyl)-4, 5-dimethyl-5-(trifluoromethyl)oxolane-2-carbonyl]amino]pyridine-2-carboxamide
15. 4-[[(2r,3s,4s,5r)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-carbonyl]amino]pyridine-2-carboxamide
16. 4-[[[(2r,3s,4s,5r)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxamide
Molecular Weight | 473.4 g/mol |
---|---|
Molecular Formula | C21H20F5N3O4 |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 104 |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 741 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
29
PharmaCompass offers a list of Suzetrigine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Suzetrigine manufacturer or Suzetrigine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Suzetrigine manufacturer or Suzetrigine supplier.
PharmaCompass also assists you with knowing the Suzetrigine API Price utilized in the formulation of products. Suzetrigine API Price is not always fixed or binding as the Suzetrigine Price is obtained through a variety of data sources. The Suzetrigine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Suzetrigine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Suzetrigine, including repackagers and relabelers. The FDA regulates Suzetrigine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Suzetrigine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Suzetrigine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Suzetrigine supplier is an individual or a company that provides Suzetrigine active pharmaceutical ingredient (API) or Suzetrigine finished formulations upon request. The Suzetrigine suppliers may include Suzetrigine API manufacturers, exporters, distributors and traders.
click here to find a list of Suzetrigine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Suzetrigine written confirmation (Suzetrigine WC) is an official document issued by a regulatory agency to a Suzetrigine manufacturer, verifying that the manufacturing facility of a Suzetrigine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Suzetrigine APIs or Suzetrigine finished pharmaceutical products to another nation, regulatory agencies frequently require a Suzetrigine WC (written confirmation) as part of the regulatory process.
click here to find a list of Suzetrigine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Suzetrigine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Suzetrigine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Suzetrigine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Suzetrigine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Suzetrigine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Suzetrigine suppliers with NDC on PharmaCompass.
Suzetrigine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Suzetrigine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Suzetrigine GMP manufacturer or Suzetrigine GMP API supplier for your needs.
A Suzetrigine CoA (Certificate of Analysis) is a formal document that attests to Suzetrigine's compliance with Suzetrigine specifications and serves as a tool for batch-level quality control.
Suzetrigine CoA mostly includes findings from lab analyses of a specific batch. For each Suzetrigine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Suzetrigine may be tested according to a variety of international standards, such as European Pharmacopoeia (Suzetrigine EP), Suzetrigine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Suzetrigine USP).